CLOSE X
GO

SBI Healthcare Opp Fund-Reg(G)

very highequitypharma & health care
426.54 -0.14(-0.03%) NAV as on 13 Jun 2025
2.77 % 1 M
19.31 % 1 Y
29.09 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

1.94

As on 31 May, 2025
age-icon Age :

25 yrs 11 m

Since 14 07 ,1999
exit_load Exit Load :

0.5%

aum AUM :

3,689.28 Crs

lock_in Lock-in :

0.50% on or before 15D, Nil after 15D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.28

Min_Investment Min. Investment :

SIP 500 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Tanmaya Desai,Pradeep Kesavan

LATEST ASSET & PORTFOLIO ALLOCATION

as on May 31 ,2025
Debt 0.08 %
Others 3.84 %
Equity 96.08 %

TOP HOLDINGS

Sun Pharmaceutical Industries...12.73 %
Divi's Laboratories Ltd.7.39 %
Max Healthcare Institute Ltd.6.40 %
Lonza Group Ag4.81 %
Cipla Ltd.4.77 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs62.03
Hospital & Healthcare Services23.31
Medical Equipment/Supplies/Accessories3.10
Chemicals2.83
See All Sectors

5-YEARS HISTORY

Financial Year2020-20212021-20222022-20232023-20242024-2025
NAV in Rs (as on 31-Mar-2025)252.90286.90281.32444.33532.43
Net Assets(Rs Crores) (as on 31-Mar-2025) 1563.95 1778.29 1589.27 2626.34 3610.51
Scheme Returns(%)(Absolute)73.5112.48-1.8658.8818.76
B'mark Returns(%)(Absolute)NANANANANA
Category Rank39/7548/7557/7614/904/102

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

SBI Healthcare Opp Fund-Reg(G)Very HighEquity426.54-0.14(-0.03%)NAV As on 13 Jun, 202514-Jul-1999Inception Date3,689.28AUM In Cr.19.31%1Y29.09%3Y24.17%5Y16.31%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity39.37-0.05(-0.13%)NAV As on 13 Jun, 202513-Jul-2018Inception Date5,507.52AUM In Cr.21.93%1Y29.75%3Y25.03%5Y21.89%Since Inception
Nippon India Pharma Fund(G)Very HighEquity513.89-0.74(-0.14%)NAV As on 13 Jun, 202505-Jun-2004Inception Date8,352.16AUM In Cr.13.72%1Y25.49%3Y21.99%5Y20.60%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.90-0.08(-0.27%)NAV As on 13 Jun, 202528-Dec-2015Inception Date1,231.67AUM In Cr.13.65%1Y24.87%3Y21.50%5Y12.27%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors